The Role of PD-L1 Testing Before Starting Immunotherapy
PD-L1 testing is an important biomarker assessment used to guide the use of immunotherapy in several cancers, particularly lung cancer
Precision Oncology
Disease-Specific Deep Dives
Molecular Subtypes of Breast Cancer and Their Treatment Implications
Molecular subtypes of Breast cancer is biologically classified using ER, PR, and HER2 status (and sometimes proliferation/genomic assays). These markers